Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraceptive Technology Update

RSS  

Articles

  • Sexual behavior: Review national survey details

    Understanding sexual behavior is an important piece of the family planning puzzle, and a new national report provides insights on current sexual practices.1
  • Pain: Chief complaint during heavy periods

    Results of a new survey indicate that in women experiencing heavy periods, pain is the most commonly reported problem.1 What are some clinical strategies to help ease these symptoms?
  • Research eyes HPV vaccine effectiveness

    Results from a new international meta-analysis study of Gardasil (Merck & Co.; Whitehouse Station, NJ), the cervical cancer vaccine, indicate the shot is nearly 100% effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer.
  • CT Updates: Hatcher recipient of leadership award

    Robert Hatcher, MD, MPH, professor of obstetrics and gynecology at Atlanta's Emory University and chairman of the editorial board for Contraceptive Technology Update, is the 2007 recipient of the Kenneth J. Ryan, MD, Physician Leadership Award.
  • New research targets Mycoplasma genitalium

    Results of a large national study of young men and women ages 18-27 suggest that Mycoplasma genitalium, a relatively new sexually transmitted infection, surpassed gonorrhea in prevalence.
  • Contraception for obese women — Check options

    Obesity is gaining ground in the United States. Are you prepared to offer women effective options? James Trussell, PhD, professor of economics and public affairs and director of the Office of Population Research at Princeton (NJ) University, reviewed current research at the 2007 Contraceptive Technology conferences to help clinicians select appropriate options.
  • Quick Start, Same Day: Jump-start pills, shot

    When it comes to initiating oral contraceptives (OCs), new research indicates that immediate initiation before start of the next menses improves short-term continuation of pill use.
  • Hormonal contraception and HIV risk: A review

    Results from past research studies have investigated a possible relationship between hormonal contraceptive use and HIV acquisition, but understanding remained poor due to inconsistent results and shortfalls in study design.
  • Letter to the editor

    I am writing to provide important details from the Today contraceptive sponge worldwide Phase III clinical trial that were not presented in your recent article in Contraceptive Technology Update.
  • Add no-needle to no-scalpel vasectomy

    How can providers ease fears when it comes to vasectomy? Take a look at no-needle, no-scalpel vasectomy (NSV), which utilizes a jet injector to spray an anesthetic solution through the skin and around the vas prior to no-scalpel vasectomy.